amitrole has been researched along with arsenic trioxide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chalmers-Redman, RM; Dai, J; Jing, Y; Tatton, WG; Waxman, S | 1 |
| Biswas, S; Byrd, JC; Jarjoura, D; Mo, X; Mone, AP; Muthusamy, N; Vargo, M; Zhao, X | 1 |
2 other study(ies) available for amitrole and arsenic trioxide
| Article | Year |
|---|---|
Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway.
Topics: Amitrole; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Catalase; Cytochrome c Group; Cytosol; Flow Cytometry; Glutathione Peroxidase; HL-60 Cells; Humans; Hydrogen Peroxide; Intracellular Membranes; K562 Cells; Kinetics; Leukemia, Promyelocytic, Acute; Membrane Potentials; Mitochondria; Oxides; Thiomalates; Tumor Cells, Cultured; U937 Cells | 1999 |
Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro.
Topics: Amino Acid Chloromethyl Ketones; Amitrole; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arsenic Trioxide; Arsenicals; Ascorbic Acid; B-Lymphocytes; Buthionine Sulfoximine; Catalase; Cell Line, Tumor; Cysteine Proteases; Cysteine Proteinase Inhibitors; Drug Evaluation, Preclinical; Drug Synergism; Enzyme Activation; Glutathione; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasm Proteins; Oxidants; Oxidative Stress; Oxides; Reactive Oxygen Species | 2010 |